Major adverse cardiovascular events associated with VEGF-targeted anticancer tyrosine kinase inhibitors: a real-life study and proposed algorithm for proactive management-Reference-Cited by-同舟云学术

Major adverse cardiovascular events associated with VEGF-targeted anticancer tyrosine kinase inhibitors: a real-life study and proposed algorithm for proactive management

Published:2022-02 Issue:1 Volume:7 Page:100338
ISSN:2059-7029
Container-title:ESMO Open
language:en
Short-container-title:ESMO Open

Author:

Vallerio P.,Orenti A.,Tosi F.,Maistrello M.,Palazzini M.,Cingarlini S.,Colombo P.,Bertuzzi M.,Spina F.,Amatu A.,Lombardo R.,Prata I.,Scaglione F.,Vighi G.D.,Severgnini B.,Siena S.,Giannattasio C.,Boracchi P.,Sartore-Bianchi A.^ORCID

Funder

Ministero della Salute

Fondazione Oncologia Niguarda Onlus

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference32 articles.

1. Tumor angiogenesis: therapeutic implications;Folkman;N Engl J Med,1971

2. Bevacizumab in combination with fluorouracil and leucovorin: an active regimen for first-line metastatic colorectal cancer;Hurwitz;J Clin Oncol,2005

3. (Pre-)clinical pharmacology and activity of pazopanib, a novel multikinase angiogenesis inhibitor;Hamberg;Oncologist,2010

4. A preclinical review of sunitinib, a multitargeted receptor tyrosine kinase inhibitor with anti-angiogenic and antitumour activities;Christensen;Ann Oncol,2007

5. Rationale and clinical results of multi-target treatments in oncology;Sartore-Bianchi;Int J Biol Markers,2007

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gastrointestinal Cancer Therapy and Cardiotoxicity;Current Treatment Options in Oncology;2024-08-05

2. Cardiovascular and cerebrovascular adverse events associated with intravitreal anti-vascular endothelial growth factor monoclonal antibodies: a World Health Organization pharmacovigilance study;Ophthalmology;2024-07

3. Arterial Thrombosis in Patients with Cancer;Cancers;2024-06-17

4. Cardiac and Nephrological Complications Related to the Use of Antiangiogenic and Anti-Programmed Cell Death Protein 1 Receptor/Programmed Cell Death Protein 1 Ligand Therapy;Genes;2024-01-28

5. A Bayesian Network to Predict Cardiovascular Diseases in Adolescents and Young Adults with Breast Cancer;2024